115 related articles for article (PubMed ID: 1656018)
1. Pharmacological profile of UP 5145-52, an original antiulcer and antisecretory agent.
Dedieu-Chaufour C; Hertz F; Caussade F; Cloarec A
J Pharmacol Exp Ther; 1991 Oct; 259(1):190-7. PubMed ID: 1656018
[TBL] [Abstract][Full Text] [Related]
2. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
Nishida A; Takinami Y; Yuki H; Kobayashi A; Akuzawa S; Kamato T; Ito H; Yamano M; Nagakura Y; Miyata K
J Pharmacol Exp Ther; 1994 Sep; 270(3):1256-61. PubMed ID: 7932178
[TBL] [Abstract][Full Text] [Related]
3. Protective action of SCH 12223 against experimentally induced gastric and intestinal lesions.
Chiu PJ; Barnett A; Siegel M; Brown AD; Gerhart C
J Pharmacol Exp Ther; 1988 Aug; 246(2):578-84. PubMed ID: 3404447
[TBL] [Abstract][Full Text] [Related]
4. Gastric antisecretory and antiulcer/cytoprotective effects of 2-cyano-3-(ethylthio-3-methylthio)-2-propenoic acid methyl ester.
Borella LE; DiJoseph JF
Arzneimittelforschung; 1989 May; 39(5):598-601. PubMed ID: 2547390
[TBL] [Abstract][Full Text] [Related]
5. Gastric cytoprotective, antisecretory and antiulcer activities of (E)-4-oxo-4-(3,4,5-trimethoxyphenyl)-2-butenoic acid (RU 38086).
Barzaghi F; Cesana R; Delevallée F; Fournex R; Nencioni A; Vincent JC; Deraedt R
Arzneimittelforschung; 1985; 35(9):1412-6. PubMed ID: 4084342
[TBL] [Abstract][Full Text] [Related]
6. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
Satoh H; Inatomi N; Nagaya H; Inada I; Nohara A; Nakamura N; Maki Y
J Pharmacol Exp Ther; 1989 Feb; 248(2):806-15. PubMed ID: 2537418
[TBL] [Abstract][Full Text] [Related]
7. Selective gastric antilesion properties of rioprostil, a prostaglandin E1 analog, in rats and dogs.
Katz LB; Shriver DA; Tobia AJ; Rosenthale ME
J Pharmacol Exp Ther; 1987 Sep; 242(3):927-33. PubMed ID: 3116199
[TBL] [Abstract][Full Text] [Related]
8. Gastric antisecretory and antiulcer effects of simvastatin in rats.
Tariq M; Khan HA; Elfaki I; Arshaduddin M; Al Moutaery M; Al Rayes H; Al Swailam R
J Gastroenterol Hepatol; 2007 Dec; 22(12):2316-23. PubMed ID: 17593225
[TBL] [Abstract][Full Text] [Related]
9. Gastric antisecretory and anti-ulcer effect of ME3407, a new benzimidazole derivative, in rats.
Tanaka J; Iida H; Abe M; Yuda Y; Inoue S; Okabe S
Arzneimittelforschung; 2004; 54(4):221-9. PubMed ID: 15146935
[TBL] [Abstract][Full Text] [Related]
10. Studies on the antisecretory, gastric anti-ulcer and cytoprotective properties of glycine.
Tariq M; Al Moutaery AR
Res Commun Mol Pathol Pharmacol; 1997 Aug; 97(2):185-98. PubMed ID: 9344231
[TBL] [Abstract][Full Text] [Related]
11. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
Amagase K; Kato S; Yamamoto H; Okabe S
Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
[TBL] [Abstract][Full Text] [Related]
12. Effects of the novel anti-ulcer agent 1-(5'-oxohexyl)-3-methyl-7-propyl xanthine on experimental ulcers and gastric secretion in rats.
Tanaka T; Bickel M; Herling AW; Sakurai M; Goto M; Hayashi S
Arzneimittelforschung; 1989 Jun; 39(6):689-94. PubMed ID: 2775336
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and pharmacological characteristics of a newly synthesized H+-K+ ATPase inhibitor, YJA20379-1, 2-amino-4,5-dihydro-8-phenylimidazole[2,1-b]thiazolo[5,4-g]benzothiazol e.
Sohn SK; Chang MS; Choi WS; Kim KB; Woo TW; Lee SB; Chung YK
Can J Physiol Pharmacol; 1999 May; 77(5):330-8. PubMed ID: 10535682
[TBL] [Abstract][Full Text] [Related]
14. Gastric anti-ulcer and cytoprotective effect of l-serine in rats.
Tariq M; Al Moutaery AR
Res Commun Mol Pathol Pharmacol; 1997 Aug; 97(2):171-84. PubMed ID: 9344230
[TBL] [Abstract][Full Text] [Related]
15. Antiulcer effects of 3-[[[2-(3,4-dimethoxyphenyl)ethyl] carbamoyl]methyl]-amino-N-methylbenzamide in experimental gastric and duodenal ulcers.
Asano M; Kurebayashi Y; Ryokawa Y; Hashizume T; Akashi A
Arzneimittelforschung; 1990 Mar; 40(3):276-81. PubMed ID: 2346535
[TBL] [Abstract][Full Text] [Related]
16. Gastric antisecretory and antiulcer activities of Cyclea peltata (Lam.) Hook. f. & Thoms. in rats.
Shine VJ; Latha PG; Shyamal S; Suja SR; Anuja GI; Sini S; Pradeep S; Rajasekharan S
J Ethnopharmacol; 2009 Sep; 125(2):350-5. PubMed ID: 19397987
[TBL] [Abstract][Full Text] [Related]
17. Effects of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl] urea with potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers in rats.
Sekiguchi H; Hamada K; Taga F; Nishino K
Arzneimittelforschung; 1993 Feb; 43(2):134-8. PubMed ID: 8096133
[TBL] [Abstract][Full Text] [Related]
18. Gastric antisecretory and antiulcer effects of WHR1582A, a compound exerting alpha-2 adrenoceptor agonist activity.
DiJoseph JF; Eash JR; Mir GN
J Pharmacol Exp Ther; 1987 Apr; 241(1):97-102. PubMed ID: 2883297
[TBL] [Abstract][Full Text] [Related]
19. Effects of indomethacin and cold-stress on gastric acid secretion and ulceration. The effects of anti-acid secretory agents in rats.
Arai I; Hirose H; Usuki C; Muramatsu M; Aihara H
Res Commun Chem Pathol Pharmacol; 1987 Sep; 57(3):313-27. PubMed ID: 3671883
[TBL] [Abstract][Full Text] [Related]
20. Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester.
Roszkowski AP; Garay GL; Baker S; Schuler M; Carter H
J Pharmacol Exp Ther; 1986 Nov; 239(2):382-9. PubMed ID: 3095537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
